Revelation Biosciences Stock Alpha and Beta Analysis

REVB Stock  USD 0.76  0.01  1.33%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Revelation Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Revelation Biosciences over a specified time horizon. Remember, high Revelation Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Revelation Biosciences' market risk premium analysis include:
Beta
1.94
Alpha
(0.84)
Risk
5.82
Sharpe Ratio
(0.09)
Expected Return
(0.50)
Please note that although Revelation Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Revelation Biosciences did 0.84  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Revelation Biosciences stock's relative risk over its benchmark. Revelation Biosciences has a beta of 1.94  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revelation Biosciences will likely underperform. At present, Revelation Biosciences' Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 0.54, whereas Book Value Per Share is forecasted to decline to 27.70.

Enterprise Value

(1.82 Million)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Revelation Biosciences Backtesting, Revelation Biosciences Valuation, Revelation Biosciences Correlation, Revelation Biosciences Hype Analysis, Revelation Biosciences Volatility, Revelation Biosciences History and analyze Revelation Biosciences Performance.
For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.

Revelation Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Revelation Biosciences market risk premium is the additional return an investor will receive from holding Revelation Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Revelation Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Revelation Biosciences' performance over market.
α-0.84   β1.94

Revelation Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Revelation Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Revelation Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Revelation Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Revelation Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revelation Biosciences shares will generate the highest return on investment. By understating and applying Revelation Biosciences stock market price indicators, traders can identify Revelation Biosciences position entry and exit signals to maximize returns.

Revelation Biosciences Return and Market Media

The median price of Revelation Biosciences for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 0.85 with a coefficient of variation of 13.11. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 0.88, and mean deviation of 0.08. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Revelation Biosciences files for secondary offering of about 5.1M shares
09/03/2024
2
Revelation Biosciences Gemini Induces Dose Dependent Significant Increases in IL-10
09/24/2024
3
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
11/08/2024
4
Warning REVB is at high risk of performing badly - MSN
11/20/2024

About Revelation Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Revelation or other stocks. Alpha measures the amount that position in Revelation Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Current Ratio0.891.222.182.23
Net Debt To EBITDA0.110.48125.95132.25

Revelation Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Revelation Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Revelation Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Revelation Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Revelation Biosciences. Please utilize our Beneish M Score to check the likelihood of Revelation Biosciences' management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Revelation Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports:
Revelation Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Revelation Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Revelation Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...